Your cart is empty
Peptagenix
Tirzepatide 10mg
Tirzepatide 10mg
Couldn't load pickup availability
Please confirm before purchasing.
This product is supplied in a vial containing powder and 2ml of antistatic bacterial water along with research information. Published literature about this product can be viewed in the resources section, and to purchase this peptide, you must sign a disclaimer to confirm the product purchase is not intended for human consumption.
Tirzepatide 10mg Overview
Tirzepatide. 10mg Peptirzepatide is a research version based on Tirzepatide. Compound class: Peptide Comment: Tirzepatide (LY3298176) is a clinical-stage dual GIP/GLP-1 agonist (‘incretin) that was developed to help manage type 2 diabetes mellitus (T2DM) [1,4] and as a novel anti-obesity medication. Structurally, a 39 amino acid linear peptide conjugated to a C20 fatty diacid moiety by a linker connected to the lysine20 residue. The dual agonist approach synergises the insulin and glucagonostatic responses compared to a GLP-1 agonist alone. It was the first dual-targeting single agent to be approved for T2DM management. This product is sold solely for research purposes only, with written consent required before order fulfilment.
Share
